First-in-man Dose Escalation Study of BAY2010112 in Patients With Prostate Cancer

Clinical trial NCT01723475 · COMPLETED

Trial details

NCT number: NCT01723475
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Prostatic Neoplasms

Start date: 2012-11-02
Primary completion: 2018-07-18
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.